التفاصيل البيبلوغرافية
| العنوان: |
Clinical Benefit of Radioiodine Administration in a Rare Case of Iodine Avid Thyroid Carcinoma with No Secretion of Thyroglobulin. |
| المؤلفون: |
Mouaden, A., Guerrouj, H., Ghfir, I., Aouad N, Ben Rais |
| المصدر: |
World Journal of Nuclear Medicine; Dec2023, Vol. 22 Issue 4, p300-305, 6p |
| مصطلحات موضوعية: |
IODINE isotopes, THYROID cancer, THYROGLOBULIN, IODINE, SECRETION, RADIONUCLIDE imaging |
| مستخلص: |
Differentiated thyroid cancer (DTC) is the most common endocrine cancer and its outcome is usually favorable. Its basic treatment is well codified, but its monitoring is much less. The value of thyroglobulin (Tg) is one of the main elements for monitoring DTC, while the use of iodine scintigraphy is becoming less recommended. In this case report, we discuss a clinical situation where a patient presented differentiated thyroid metastatic lesions confirmed by biopsy, uptaking radioactive iodine, with undetectable levels of Tg (in the absence of autoantibodies). We discuss the various hypotheses explaining this clinical situation, the potential advantages of performing periodic iodine scintigraphy in some intermediate and high-risk patients and report the documented clinical benefit of radioiodine therapy. [ABSTRACT FROM AUTHOR] |
|
Copyright of World Journal of Nuclear Medicine is the property of Thieme Medical & Scientific Publishers Private Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder